Decreased inappropriate shocks with new generation ICDs in children and patients with congenital heart disease

OBJECTIVE Inappropriate implantable cardioverter defibrillator (ICD) shocks in children and patients with congenital heart disease (CHD) remain a major complication of device therapy, occurring in as many as 50% of children with ICDs. New generation devices include algorithms designed to minimize inappropriate shocks. This study aimed to evaluate the effect of new generation ICDs on the incidence of inappropriate shocks in the pediatric and CHD population. DESIGN Retrospective study of patients with CHD or under age 25 receiving ICDs between 2000 and 2015. New generation ICDs were defined as those with Medtronic "SmartShock" algorithms. RESULTS Two hundred eight devices were implanted in 146 patients. Rates of inappropriate shocks were similar between diagnoses (P = .71). The rate of inappropriate shock was 15% over median 5.8 years follow-up. In the 36 patients (25%) with new generation ICDs, the rate of inappropriate shock was 6.3% over 4 years. Comparing old to new generation ICDs, freedom from first inappropriate shock was 90.6% versus 97.1% at 1 year and 80.4% versus 97.1% at 3 years (P = .01). Lead fracture was associated with having inappropriate shock (hazard ratio 8.5, P < .0001), and there was no significant difference between the device groups when lead fractures were excluded. Clinical actions were taken in 69% of patients after initial inappropriate shock (such as medication or program change, system revision, or explant). When an action was taken, subsequent inappropriate shock was reduced (5.3% vs 49.2% at 1 year; P = .002). CONCLUSIONS Pediatric and CHD patients are experiencing reduced inappropriate shocks with new generation ICD systems, though reduced lead fracture may account for this improvement. Clinical interventions after inappropriate shock favorably impact the subsequent rate of shocks once an inappropriate shock occurs.

[1]  A. Moss,et al.  Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). , 2016, Heart rhythm.

[2]  I. van der Tweel,et al.  Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study). , 2016, The American journal of cardiology.

[3]  J. Brachmann,et al.  Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study , 2015, Clinical Research in Cardiology.

[4]  A. Auricchio,et al.  Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. , 2015, Heart rhythm.

[5]  S. Etheridge,et al.  Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies. , 2015, Heart rhythm.

[6]  D. Babuty,et al.  Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. , 2014, JACC. Heart failure.

[7]  K. Gauvreau,et al.  Time Dependence of Risks and Benefits in Pediatric Primary Prevention Implantable Cardioverter-Defibrillator Therapy , 2014, Circulation. Arrhythmia and electrophysiology.

[8]  K. Gauvreau,et al.  Psychiatric Functioning and Quality of Life in Young Patients With Cardiac Rhythm Devices , 2014, Pediatrics.

[9]  C. Berul,et al.  Multi-Institutional Study of Implantable Defibrillator Lead Performance in Children and Young Adults: Results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) Study , 2013, Circulation.

[10]  A. Proclemer,et al.  Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. , 2013, JAMA.

[11]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[12]  P. Kannankeril,et al.  Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients. , 2012, Heart rhythm.

[13]  M. Schalij,et al.  Update on Small‐Diameter Implantable Cardioverter‐Defibrillator Leads Performance , 2012, Pacing and clinical electrophysiology : PACE.

[14]  S. Saba,et al.  Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  Andrew S. Mugglin,et al.  Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure: Implications for Patient Management , 2011, Circulation.

[16]  M. Gollob,et al.  Psychological Adjustment in ICD Patients Living With Advisory Fidelis Leads , 2011, Journal of cardiovascular electrophysiology.

[17]  D. Atkins,et al.  Multicenter Study of the Effectiveness of Implantable Cardioverter Defibrillators in Children and Young Adults With Heart Disease , 2011, Pediatric Cardiology.

[18]  A. Elvan,et al.  Characteristics of Sprint Fidelis lead failure. , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[19]  I. Law,et al.  Inappropriate ICD Discharges in Single‐Chamber Versus Dual‐Chamber Devices in the Pediatric and Young Adult Population , 2009, Journal of cardiovascular electrophysiology.

[20]  M. Gollob,et al.  Accelerating risk of Fidelis lead fracture. , 2008, Heart rhythm.

[21]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[22]  Wojciech Zareba,et al.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.

[23]  L. F. Moreira,et al.  Incidence of shock and quality of life in young patients with implantable cardioverter-defibrillator. , 2007, Arquivos brasileiros de cardiologia.

[24]  B. Zrenner,et al.  Implantable cardioverter defibrillator (ICD) in children. , 2006, International journal of cardiology.

[25]  N. Blom,et al.  Implantable cardioverter defibrillator implantation in children in The Netherlands , 2005, European Journal of Pediatrics.

[26]  Michael O. Sweeney,et al.  Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.

[27]  P. Coumel,et al.  Death Due to an Implantable Cardioverter Defibrillator , 2004, Journal of cardiovascular electrophysiology.

[28]  T. Paul,et al.  High Incidence of Appropriate and Inappropriate ICD Therapies in Children and Adolescents with Implantable Cardioverter Defibrillator , 2004, Pacing and clinical electrophysiology : PACE.

[29]  A. Russo,et al.  Racial Differences in Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT) A Comparison of Whites Versus Blacks , 2003, Circulation.